Systems, devices, and methods for episode detection and evaluation

A symptom, monitoring system technology, applied in the direction of error detection/correction, application, telemetry patient monitoring, etc., can solve the problems of confusing users, blows, and unclear patients.

Active Publication Date: 2018-03-27
ABBOTT DIABETES CARE INC
View PDF14 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Analyte monitoring devices and systems are capable of generating large volumes of data that can overwhelm and confuse users to the point where explanations for what drives excursions or high variability are nearly impossible to obtain
In addition, recording information that can be beneficial in understanding causality can be burdensome because it is not clear to the patient what information should be recorded

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Systems, devices, and methods for episode detection and evaluation
  • Systems, devices, and methods for episode detection and evaluation
  • Systems, devices, and methods for episode detection and evaluation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0059] EIS can be used to detect previous, current and / or future symptom onset. As used herein, the term symptom onset does not mean every change in analyte level, but rather those changes that contribute significantly to the subject's analyte variability, such as high glucose and low glucose spikes. Symptomatic episodes can also include clinically significant glucose excursions or events, such as rapid increases or rapid decreases in glucose levels. Different criteria can be used to define a set of analyte level measures as a symptom onset, including the magnitude of an analyte measure, the rate of change between consecutive analyte measures or other sets of measures in close time, the analyte in which a threshold level is exceeded Number of measurements (or durations), breakthrough of a threshold by integrated area of ​​a series of analyte measurements, any combination thereof, etc. The detection conditions for these onset of symptoms are described in US Patent Publication ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Systems, devices, and methods are provided that allow detection of episodes in analyte measurement, prompting a patient to self-report possible causes for the episodes. Correlation of possible causeswith detected episodes assists patient behavior modification to reduce the occurrence of episodes.

Description

[0001] References to related applications [0002] This patent application claims the benefit and priority of U.S. Provisional Patent Application Serial No. 62 / 189,137, filed July 6, 2015, and U.S. Provisional Patent Application Serial No. 62 / 191,208, filed July 10, 2015, above Both patent applications are hereby incorporated by reference in their entirety for all purposes. technical field [0003] The subject matter described herein relates to systems, devices, and methods capable of determining or predicting the onset of symptom onset in analyte data and assessing conditions associated with or potentially causing the onset of the symptom. Background technique [0004] Several systems have been developed for the automated monitoring of analytes such as glucose in body fluids such as blood, interstitial fluid (ISF), dermal fluids of the dermis, or other biological fluids. [0005] These systems can provide health care providers (HCPs), diabetics, and / or caregivers with assa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61B5/00G06Q50/22H04M1/725
CPCA61B5/0004A61B5/14532A61B5/4839A61B5/7275A61B5/7282A61B5/7435A61B5/7475G16H10/40G16H10/60G16H40/67G16H50/30G06F30/20G06F11/366
Inventor 加里·A·海特蒂莫西·C·邓恩纳森·克鲁泰丹尼尔·M·伯恩斯坦埃里克·L·戴维斯
Owner ABBOTT DIABETES CARE INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products